- In July 2024, Mölnlycke Health Care announced a USD 15 million investment in MediWound Ltd., a global leader in next-generation enzymatic therapeutics for non-surgical wound debridement. This strategic investment aligns with Mölnlycke's strategy to bring radical innovations into the wound care space and provide alternative solutions to traditional debridement, aiming to improve clinical outcomes and patient experience
- In April 2024, Mölnlycke also signed an agreement to acquire P.G.F. Industry Solutions GmbH, the Austrian manufacturer of Granudacyn wound cleansing and moisturising solutions. This acquisition further strengthens Mölnlycke's portfolio in wound care, including products that support the debridement process by cleansing the wound bed
- In September 2023, Medtronic launched its SurgiSleeve Wound Protector, which, while primarily a wound protector, plays a role in facilitating better surgical site exposure and protection during procedures, which can indirectly support effective debridement and wound management by minimizing contamination
- In October 2023, Zimmer Biomet highlighted new product introductions and advancements in its portfolio for musculoskeletal healthcare during its 2023 financial reports, often including surgical instruments and tools that support effective wound debridement in orthopedic procedures. While a specific debridement tool launch wasn't individually highlighted in their public summaries, their ongoing innovation in surgical solutions is relevant
